Biological and Pharmaceutical Bulletin
The Pharmaceutical Society of Japan, established in 1880, is one of Japan’s oldest and most distinguished academic societies. The Society currently has around 18,000 members. It publishes three monthly scientific journals. Chemical and Pharmaceutical Bulletin (Chem. Pharm. Bull.) began publication in 1953 as Pharmaceutical Bulletin. It covers chemistry fields in the pharmaceutical and health sciences. Biological and Pharmaceutical Bulletin (Biol. Pharm. Bull.) began publication in 1978 as the Journal of Pharmacobio-Dynamics. It covers various biological topics in the pharmaceutical and health sciences. A fourth Society journal, the Journal of Health Science, was merged with Biol. Pharm. Bull. in 2012. Yakugaku Zasshi (Japanese for “Pharmaceutical Science Journal”) has the longest history, with publication beginning in 1881. Yakugaku Zasshi is published mostly in Japanese, except for some articles related to clinical pharmacy and pharmaceutical education, which are published in English.
The main aim of the Society’s journals is to advance the pharmaceutical sciences with research reports, information exchange, and high-quality discussion. The average review time for articles submitted to the journals is around one month for first decision. The complete texts of all of the Society’s journals can be freely accessed through J-STAGE. The Society’s editorial committee hopes that the content of its journals will be useful to your research, and also invites you to submit your own work to the journals.

Chairman of Committee
Ken-ichi Hosoya
Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama

Read more
9,719 registered articles
(updated on February 20, 2019)
Online ISSN : 1347-5215
Print ISSN : 0918-6158
Featured article
Volume 42 (2019) Issue 2 Pages 273-279
Hepatic and Intrahepatic Targeting of Hydrogen Sulfide Prodrug by Bioconjugation Read more
Editor’s picks

The delivery of hydrogen sulfide (H2S) to liver is expected for the treatment of hepatic diseases. K. Sakai et al. developed two types of sulfo-albumins, macromolecular H2S prodrugs, for hepatic and intrahepatic targeting of H2S. Sulfide groups (source of H2S) were covalently bound to succinylated (Suc) and galactosylated (Gal) bovine serum albumin (BSA) for targeted delivery of H2S to hepatic nonparenchymal cells and parenchymal cells, respectively. Their results demonstrated targeted delivery of H2S prodrug to a specific type of liver cells using the chemical modification of targeting ligands.

View the past featured articles
View all articles in Current issue
Most viewed articles Jan.2019
Share this page
Select past volume & issue
Journal news & Announcements
  • Biol. Pharm. Bull. Vol. 41 No. 10
    Current Topics: Transporter Research Yields New Discoveries in Life Sciences